Pharmacokinetics of Red Blood Cell Phenothiazine and Clinical Effects
- 1 July 1976
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 33 (7) , 862-866
- https://doi.org/10.1001/archpsyc.1976.01770070092011
Abstract
• Pharmacokinetics of the phenothiazine, butaperazine, were studied in relationship to acute dystonic reactions. Dystonias appeared on falling drug concentrations, more than one half-life after plasma and red blood cell (RBC) peak butaperazine concentrations.Red blood cellbutaperazine kinetics differentiated better than didplasmabutaperazine levels those subjects in whom dystonias would develop from those in whom they did not. We conclude that RBC phenothiazine levels may more clearly reflect drug concentration at critical brain sites than do simple plasma drug levels. Furthermore, dystonic reactions may be the result of differential sensitivity of two or more receptor systems to receptor blockade by antischizophrenic agents.Keywords
This publication has 2 references indexed in Scilit:
- Dopamine Receptors in the BrainScience, 1975
- USE OF METHYLPHENIDATE TO COUNTERACT ACUTE DYSTONIC EFFECTS OF PHENOTHIAZINESAmerican Journal of Psychiatry, 1966